Defining the susceptibility of colorectal cancers to BH3-mimetic compounds. - Luo MJ; Palmieri M; Riffkin CD; Sakthianandeswaren A; Djajawi TM; Hirokawa Y; Shuttleworth V; Segal DH; White CA; Nhu D; Lessene G; Lee M; et al. (Cell death & disease, 2020)